HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by James, R. W. Articles by Clegg, R. J. Search for Related Content PubMed PubMed Citation Articles by James, R. W. Articles by Clegg, R. J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 30, 159-169, Copyright © 1989 by Lipid Research, Inc.

ARTICLES

Apolipoprotein B metabolism in homozygous familial hypercholesterolemia

RW James, B Martin, D Pometta, JC Fruchart, P Duriez, P Puchois, JP Farriaux, A Tacquet, T Demant and RJ Clegg
Division of Diabetology, Cantonal Hospital, Geneva, Switzerland.

This report describes the metabolism of apolipoprotein B-containing lipoproteins in seven familial hypercholesterolemic (FH) homozygotes and compares the results to the values obtained from five healthy control subjects. The concentration, composition, and metabolism of large, triglyceride-rich very low density lipoproteins (VLDL1, Sf 60- 400) were the same in the control and FH groups, indicating that this component of the VLDL delipidation cascade ws unaffected by the absence of receptors. In contrast, familial hypercholesterolemic small VLDL2 (Sf 20-60) was enriched with cholesterol and depleted in triglyceride. Moreover, its plasma concentration was elevated as a result of an increase in its synthesis and a defect in the removal of a remnant population within this density interval. The latter accounted for up to 50% of the total mass of the fraction. Onward transfer of apolipoprotein B (apoB) from small VLDL through intermediate density lipoprotein (IDL) to low density lipoprotein (LDL) was retarded, suggesting that receptors were involved in this supposedly lipase- mediated event. IDL and LDL concentrations increased up to fourfold above normal in the plasma of the FH patients due partly to the delay in maturation and partly to defective direct catabolism. We conclude that the LDL receptor plays multiple and important roles in the metabolism and transformation of apoB-containing particles in the Sf 0- 400 flotation interval.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Adiels, S.-O. Olofsson, M.-R. Taskinen, and J. Boren Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1225 - 1236. [Abstract] [Full Text] [PDF]

				D. A. Blasiole, A. T. Oler, and A. D. Attie Regulation of ApoB Secretion by the Low Density Lipoprotein Receptor Requires Exit from the Endoplasmic Reticulum and Interaction with ApoE or ApoB J. Biol. Chem., April 25, 2008; 283(17): 11374 - 11381. [Abstract] [Full Text] [PDF]

				G. D. Kolovou, G. V.Z. Dedoussis, K. K. Anagnostopoulou, G. Ch. Hatzigeorgiou, K. D. Salpea, D. M. Choumerianou, S. Rammos, D. P. Mikhailidis, and D. V. Cokkinos Management of a Patient With a Null Low-Density Lipoprotein Receptor Mutation: A Case Report Angiology, January 1, 2007; 57(6): 729 - 732. [Abstract] [PDF]

				J. S. Millar, C. Maugeais, K. Ikewaki, D. M. Kolansky, P.H. R. Barrett, E. C. Budreck, R. C. Boston, N. Tada, S. Mochizuki, J. C. Defesche, et al. Complete Deficiency of the Low-Density Lipoprotein Receptor Is Associated With Increased Apolipoprotein B-100 Production Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 560 - 565. [Abstract] [Full Text] [PDF]

				A. D. Attie The Mystery of PCSK9 Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1337 - 1339. [Full Text] [PDF]

				K. Ouguerram, M. Chetiveaux, Y. Zair, P. Costet, M. Abifadel, M. Varret, C. Boileau, T. Magot, and M. Krempf Apolipoprotein B100 Metabolism in Autosomal-Dominant Hypercholesterolemia Related to Mutations in PCSK9 Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1448 - 1453. [Abstract] [Full Text] [PDF]

				A. J. Tremblay, B. Lamarche, I. L. Ruel, J.-C. Hogue, J. Bergeron, C. Gagne, and P. Couture Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation J. Lipid Res., May 1, 2004; 45(5): 866 - 872. [Abstract] [Full Text] [PDF]

				B. H. C. M. T. Prinsen, J. A. Romijn, P. H. Bisschop, M. M. J. de Barse, P. H. R. Barrett, M. Ackermans, R. Berger, T. J. Rabelink, and M. G. M. de Sain-van der Velden Endogenous cholesterol synthesis is associated with VLDL-2 apoB-100 production in healthy humans J. Lipid Res., July 1, 2003; 44(7): 1341 - 1348. [Abstract] [Full Text] [PDF]

				K. K. Berneis and R. M. Krauss Metabolic origins and clinical significance of LDL heterogeneity J. Lipid Res., September 1, 2002; 43(9): 1363 - 1379. [Abstract] [Full Text] [PDF]

				J. S. Millar, C. Maugeais, I. V. Fuki, and D. J. Rader Normal Production Rate of Apolipoprotein B in LDL Receptor-Deficient Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 989 - 994. [Abstract] [Full Text] [PDF]

				D. L. Gillian-Daniel, P. W. Bates, A. Tebon, and A. D. Attie Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B PNAS, April 2, 2002; 99(7): 4337 - 4342. [Abstract] [Full Text] [PDF]

				C. J. Packard, T. Demant, J. P. Stewart, D. Bedford, M. J. Caslake, G. Schwertfeger, A. Bedynek, J. Shepherd, and D. Seidel Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions J. Lipid Res., February 1, 2000; 41(2): 305 - 318. [Abstract] [Full Text]

				C. J. Packard and J. Shepherd Lipoprotein Heterogeneity and Apolipoprotein B Metabolism Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3542 - 3556. [Abstract] [Full Text]

				C. Maugeais, S. Braschi, K. Ouguerram, P. Maugeais, P. Mahot, B. Jacotot, D. Darmaun, T. Magot, and M. Krempf Lipoprotein Kinetics in Patients With Analbuminemia : Evidence for the Role of Serum Albumin in Controlling Lipoprotein Metabolism Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1369 - 1375. [Abstract] [Full Text]

				R. Malmstrom, C. J. Packard, T. D. G. Watson, S. Rannikko, M. Caslake, D. Bedford, P. Stewart, H. Yki-Jarvinen, J. Shepherd, and M.-R. Taskinen Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1454 - 1464. [Abstract] [Full Text]

				J. Ferrieres, J. Lambert, S. Lussier-Cacan, and J. Davignon Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation Circulation, August 1, 1995; 92(3): 290 - 295. [Abstract] [Full Text]

				D. L. Gillian-Daniel, P. W. Bates, A. Tebon, and A. D. Attie Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B PNAS, April 2, 2002; 99(7): 4337 - 4342. [Abstract] [Full Text] [PDF]